- Home
- AMPS vs ARCT Comparison
AMPS vs ARCT Comparison
Compare AMPS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPS
- ARCT
- Stock Information
- Founded
- AMPS 2009
- ARCT 2013
- Country
- AMPS United States
- ARCT United States
- Employees
- AMPS N/A
- ARCT N/A
- Industry
- AMPS Electric Utilities: Central
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- AMPS Utilities
- ARCT Health Care
- Exchange
- AMPS Nasdaq
- ARCT Nasdaq
- Market Cap
- AMPS 608.0M
- ARCT 487.0M
- IPO Year
- AMPS N/A
- ARCT N/A
- Fundamental
- Price
- AMPS $3.74
- ARCT $17.12
- Analyst Decision
- AMPS Strong Buy
- ARCT Strong Buy
- Analyst Count
- AMPS 9
- ARCT 7
- Target Price
- AMPS $5.38
- ARCT $65.00
- AVG Volume (30 Days)
- AMPS 1.1M
- ARCT 356.8K
- Earning Date
- AMPS 03-13-2025
- ARCT 03-06-2025
- Dividend Yield
- AMPS N/A
- ARCT N/A
- EPS Growth
- AMPS N/A
- ARCT N/A
- EPS
- AMPS 0.22
- ARCT N/A
- Revenue
- AMPS $185,992,000.00
- ARCT $160,399,000.00
- Revenue This Year
- AMPS $30.56
- ARCT $7.33
- Revenue Next Year
- AMPS $17.93
- ARCT $4.71
- P/E Ratio
- AMPS $16.98
- ARCT N/A
- Revenue Growth
- AMPS 25.90
- ARCT N/A
- 52 Week Low
- AMPS $2.71
- ARCT $14.30
- 52 Week High
- AMPS $7.28
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- AMPS 45.89
- ARCT 48.75
- Support Level
- AMPS $3.82
- ARCT $15.82
- Resistance Level
- AMPS $4.24
- ARCT $17.93
- Average True Range (ATR)
- AMPS 0.28
- ARCT 1.51
- MACD
- AMPS -0.06
- ARCT -0.04
- Stochastic Oscillator
- AMPS 36.14
- ARCT 23.90
About AMPS Altus Power Inc.
Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.